CN113502158A - 金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 - Google Patents
金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 Download PDFInfo
- Publication number
- CN113502158A CN113502158A CN202110796557.0A CN202110796557A CN113502158A CN 113502158 A CN113502158 A CN 113502158A CN 202110796557 A CN202110796557 A CN 202110796557A CN 113502158 A CN113502158 A CN 113502158A
- Authority
- CN
- China
- Prior art keywords
- bilirubin
- solution
- gold
- concentration
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 title claims abstract description 184
- 239000010931 gold Substances 0.000 title claims abstract description 95
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 92
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 91
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 238000001514 detection method Methods 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000000243 solution Substances 0.000 claims abstract description 83
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 38
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 38
- 239000011259 mixed solution Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 229910004042 HAuCl4 Inorganic materials 0.000 claims abstract description 10
- 238000004108 freeze drying Methods 0.000 claims abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- 239000007853 buffer solution Substances 0.000 claims description 10
- 238000007865 diluting Methods 0.000 claims description 10
- 238000005286 illumination Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 23
- 239000011701 zinc Substances 0.000 description 17
- 238000010791 quenching Methods 0.000 description 15
- 230000000171 quenching effect Effects 0.000 description 11
- 238000011084 recovery Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 101150113720 aunc gene Proteins 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 239000011241 protective layer Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- -1 gold ions Chemical class 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- NTDFJPCHHGBHCO-UHFFFAOYSA-N 7,9-dihydro-3H-purine-2,6,8-trione Chemical compound OC1=NC(O)=C2NC(O)=NC2=N1.N1C(=O)NC(=O)C2=C1NC(=O)N2 NTDFJPCHHGBHCO-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010012559 Developmental delay Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008876 conformational transition Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000004298 light response Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Manufacturing & Machinery (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110796557.0A CN113502158B (zh) | 2021-07-14 | 2021-07-14 | 金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110796557.0A CN113502158B (zh) | 2021-07-14 | 2021-07-14 | 金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113502158A true CN113502158A (zh) | 2021-10-15 |
CN113502158B CN113502158B (zh) | 2023-03-14 |
Family
ID=78013347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110796557.0A Active CN113502158B (zh) | 2021-07-14 | 2021-07-14 | 金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113502158B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114951683A (zh) * | 2022-05-27 | 2022-08-30 | 深圳技术大学 | 金纳米簇的合成方法及其六价铬离子的检测方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104614355A (zh) * | 2015-02-06 | 2015-05-13 | 盐城工学院 | 一种基于牛血清蛋白功能化的金纳米团簇光散射探针检测Cu2+浓度的方法 |
CN106947471A (zh) * | 2017-03-08 | 2017-07-14 | 吉林大学 | 一种水溶性的金纳米簇荧光材料、制备方法及应用 |
CN112008091A (zh) * | 2020-08-14 | 2020-12-01 | 福建医科大学 | 一种高灵敏、低毒、具氧化模拟酶活性的金纳米簇制备方法与应用 |
CN112775432A (zh) * | 2019-10-23 | 2021-05-11 | 武汉大学苏州研究院 | 一种基于牛血清白蛋白的短波红外荧光金纳米簇及其制备方法与应用 |
-
2021
- 2021-07-14 CN CN202110796557.0A patent/CN113502158B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104614355A (zh) * | 2015-02-06 | 2015-05-13 | 盐城工学院 | 一种基于牛血清蛋白功能化的金纳米团簇光散射探针检测Cu2+浓度的方法 |
CN106947471A (zh) * | 2017-03-08 | 2017-07-14 | 吉林大学 | 一种水溶性的金纳米簇荧光材料、制备方法及应用 |
CN112775432A (zh) * | 2019-10-23 | 2021-05-11 | 武汉大学苏州研究院 | 一种基于牛血清白蛋白的短波红外荧光金纳米簇及其制备方法与应用 |
CN112008091A (zh) * | 2020-08-14 | 2020-12-01 | 福建医科大学 | 一种高灵敏、低毒、具氧化模拟酶活性的金纳米簇制备方法与应用 |
Non-Patent Citations (4)
Title |
---|
MENGFAN XIA,等: "Aggregation-induced emission enhancement of gold nanoclusters in metal–organic frameworks for highly sensitive fluorescent detection of bilirubin", 《ANALYST》 * |
SOUJANYA AKAVARAM 等: "Trypsin encapsulated gold-silver bimetallic nanoclusters for recognition of quinalphos via fluorescence quenching and of Zn2+ and Cd2+ ions via fluorescence enhancement", 《JOURNAL OF MOLECULAR LIQUIDS》 * |
WENXIANG XIAO等: "A ratiometric bilirubin sensor based on a fluorescent gold nanocluster film with dual emissions", 《ANAL. METHODS》 * |
郑名,等: "基于胆红素荧光增强效应的锌离子探针特性研究", 《光谱学与光谱分析》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114951683A (zh) * | 2022-05-27 | 2022-08-30 | 深圳技术大学 | 金纳米簇的合成方法及其六价铬离子的检测方法 |
CN114951683B (zh) * | 2022-05-27 | 2023-06-27 | 深圳技术大学 | 金纳米簇的合成方法及其六价铬离子的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113502158B (zh) | 2023-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Luo et al. | Glutathione-stabilized Cu nanoclusters as fluorescent probes for sensing pH and vitamin B1 | |
Chen et al. | Sensitive and selective detection of glutathione based on resonance light scattering using sensitive gold nanoparticles as colorimetric probes | |
CN104745194B (zh) | 量子点@铜纳米簇比率荧光探针的制备方法及其Cu2+检测应用 | |
KR102021663B1 (ko) | 자성비드 기반의 효소 모방 나노자임을 이용한 타켓 물질의 검출 방법 | |
Agoston et al. | Rapid isolation and detection of erythropoietin in blood plasma by magnetic core gold nanoparticles and portable Raman spectroscopy | |
Shi et al. | Aptamer based fluorometric β-lactoglobulin assay based on the use of magnetic nanoparticles and carbon dots | |
CN112175608B (zh) | 一种蓝色荧光银纳米团簇及其制备方法与应用 | |
Zhao et al. | A novel bionic magnetic SERS aptasensor for the ultrasensitive detection of deoxynivalenol based on “dual antennae” nano-silver | |
Wu et al. | Electrochemiluminescent aptamer-sensor for alpha synuclein oligomer based on a metal–organic framework | |
He et al. | Characterization of the interaction between mercaptoethylamine capped CdTe quantum dots with human serum albumin and its analytical application | |
CN113502158B (zh) | 金纳米簇的制备方法及其在胆红素和锌离子联级检测中的应用 | |
Lu et al. | A novel dual response ratiometric fluorescent probe for the determination of H 2 O 2 and glucose via etching of silver nanoparticles | |
CN114032095B (zh) | 硅碳量子点的制备方法及其应用 | |
Wang et al. | Competitive ELISA based on pH-responsive persistent luminescence nanoparticles for autofluorescence-free biosensor determination of ochratoxin A in cereals | |
Guo et al. | Covalent organic framework-gold nanoparticle heterostructures amplified dynamic light scattering immunosensor for ultrasensitive detection of NT-proBNP in whole blood | |
Ma et al. | A sensitive and selective chemosensor for GSSG detection based on the recovered fluorescence of NDPA-Fe3O4@ SiO2-Cu (II) nanomaterial | |
Li et al. | A magnetic nanoparticle-based aptasensor for selective and sensitive determination of lysozyme with strongly scattering silver nanoparticles | |
Liu et al. | A label-free “turn-on” fluorescence platform for glucose based on AuNCs@ MnO 2 nanocomposites | |
Deng et al. | A traffic light-type sensitive visual detection of mercury by golden nanoclusters mixed with fluorescein | |
Zou et al. | Sensitive and Selective Detection of Mercury Ions in Aqueous Media Using an Oligonucleotide-functionalized Nanosensor and SERS Chip | |
Fu et al. | Highly sensitive and naked eye dual-readout method for L-cysteine detection based on the NSET of fluorophore functionalized gold nanoparticles | |
CN113588627B (zh) | 一种基于激光诱导击穿光谱的二价铜离子检测方法和应用 | |
TWI830913B (zh) | 使用金奈米粒子之精胺的直接比色法檢測 | |
CN114381257A (zh) | 一种基于硫代乳酸保护的近红外发光金纳米簇比率型荧光探针及其在银离子检测中的应用 | |
Singh et al. | Smartphone‐Based Noninvasive Glucose Monitoring in Diabetic Patients Utilizing Enhanced Chemiluminescence Imaging Technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20211015 Assignee: Guilin Xianjingkuangbao Technology Development Co.,Ltd. Assignor: GUILIN University OF ELECTRONIC TECHNOLOGY Contract record no.: X2023980046674 Denomination of invention: Preparation Method of Gold Nanoclusters and Its Application in Bilirubin and Zinc Ion Linked Detection Granted publication date: 20230314 License type: Common License Record date: 20231109 Application publication date: 20211015 Assignee: Guilin Sensing Material Technology Co.,Ltd. Assignor: GUILIN University OF ELECTRONIC TECHNOLOGY Contract record no.: X2023980046110 Denomination of invention: Preparation Method of Gold Nanoclusters and Its Application in Bilirubin and Zinc Ion Linked Detection Granted publication date: 20230314 License type: Common License Record date: 20231107 Application publication date: 20211015 Assignee: Guilin Xingyuan Technology Co.,Ltd. Assignor: GUILIN University OF ELECTRONIC TECHNOLOGY Contract record no.: X2023980045835 Denomination of invention: Preparation Method of Gold Nanoclusters and Its Application in Bilirubin and Zinc Ion Linked Detection Granted publication date: 20230314 License type: Common License Record date: 20231107 |